The P2 Receptor Antagonist PPADS Supports Recovery from Experimental Stroke In Vivo

• Alexandra B. Lämmer,

  Affiliations Department of Neurology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany, Department of Neurology, University of Leipzig, Leipzig, Germany

  ⨯
• Alexander Beck,

  Affiliation Department of Neurology, Friedrich-Alexander-University of Erlangen-Nuremberg, Erlangen, Germany

  ⨯
• Benjamin Grummich,

  Affiliation Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

  ⨯
• Annette Förschler,

  Affiliation Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany

  ⨯
• Thomas Krügel,

  Affiliation Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

  ⨯
• Thomas Kahn,

  Affiliation Department of Diagnostic and Interventional Radiology, University of Leipzig, Leipzig, Germany

  ⨯
• Dietmar Schneider,

  Affiliation Department of Neurology, University of Leipzig, Leipzig, Germany

  ⨯
• Peter Illes,

  Affiliation Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

  ⨯
• Heike Franke,

  Affiliation Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

  ⨯
• Ute Krügel

  * E-mail: ute.kruegel@medizin.uni-leipzig.de

  Affiliation Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany

  ⨯